How long will your body produce modified spike protein after the COVID jab? That’s been a question people have been asking ever since the rollout of the first mRNA shots. A paper published in the Proteomics Clinical Applications journal in mid-August 20231 tried to answer that question, and it’s not great news, as the answer,… Read More »
At least 16,183 people say they’ve developed tinnitus after receiving a COVID-19 shot.1,2 The reports were filed with the U.S. Centers for Disease Control and Prevention’s Vaccine Adverse Event Reporting System (VAERS) database. But considering only between 1%3 and 10%4 of adverse reactions are ever reported to VAERS, the actual number is likely much higher.… Read More »
Pfizer’s Paxlovid was granted emergency use authorization to treat mild to moderate COVID-19 in December 2021.1 The drug consists of nirmatrelvir tablets — the antiviral component — and ritonavir tablets, which are intended to slow the breakdown of nirmatrelvir.2 What started out as a slow rollout — only 40,000 or fewer prescriptions were written for… Read More »
SANDSIV’s highly secure, hyper-modern, on-premises VoC solution has enhanced Swisscom’s position as a leader in Customer Experience ZURICH, Switzerland (May, 31 2022) — Swisscom, Switzerland’s leading telecommunications provider, and SANDSIV, the global leader in Customer Experience Management (CXM) and Voice of the Customer (VoC) enterprise solutions, are celebrating year one of a successful partnership that… Read More »
Hi friends! Happy Thursday! I’ve got a new episode up on the ‘pod and today I’m chatting with Daisy Andrea Bravo about abs after baby. When you hear “abs after baby,” it’s easy to think about getting a six-pack (or getting your six-pack back) because that’s the messaging that we’re constantly bombarded with online. I’m… Read More »
The U.S. Food and Drug Administration reiterated its stance that the benefits of Moderna’s COVID-19 vaccine outweigh its risks on Friday after several Nordic countries began restricting its use for certain age groups due to concerns about a rare heart-related side effect. The FDA responded after health officials in Finland said Thursday that males under… Read More »